Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -30,740 | -2,953 | -2,194 |
| Depreciation Amortization | 232 | 2 | 0 |
| Accounts payable and accrued liabilities | 1,343 | 252 | 38 |
| Other Working Capital | 4,241 | 1,791 | 47 |
| Other Operating Activity | 3,189 | 146 | 603 |
| Operating Cash Flow | $-21,734 | $-763 | $-1,506 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -36,806 | N/A | N/A |
| PPE Investments | N/A | N/A | -2 |
| Investing Cash Flow | $-36,806 | $0 | $-2 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | 701 | 1,125 |
| Common Stock Issued | 49,924 | -66 | N/A |
| Common Stock Repurchased | -274 | N/A | N/A |
| Other Financing Activity | 36,663 | 0 | 0 |
| Financing Cash Flow | $86,314 | $634 | $1,125 |
| Beginning Cash Position | 204 | 333 | 716 |
| End Cash Position | 27,978 | 204 | 333 |
| Net Cash Flow | $27,773 | $-129 | $-383 |
| Free Cash Flow | |||
| Operating Cash Flow | -21,734 | -763 | -1,506 |
| Capital Expenditure | N/A | N/A | -2 |
| Free Cash Flow | -21,734 | -763 | -1,508 |